|

S&P 500 Index: Earnings per share expected to show V-shaped recovery – NBF

In the US, the consensus of equity analysts currently sees a 26% increase in S&P 500 earnings per share (EPS) in 2021, with a return to peak about a year from now. This is an ambitious forecast considering the current state of the US labour market and the failure of Congress to agree on another round of fiscal stimulus in support of household income. Absent a new round of stimulus, economists at the National Bank of Canada (NBF) fear a relapse of economic activity as labour income takes a hit, forcing some homeowners into insolvency.

Key quotes

“In the US, the consensus of equity analysts currently sees a 26% increase in S&P 500 EPS in 2021, with a return to peak about a year from now. The consensus expects this earnings recovery to be V-shaped and broadbased: seven of the 11 main sectors are forecast to match or top their pre-pandemic EPS. This is an ambitious forecast considering the current state of the US labour market and the failure of Congress to agree on another round of fiscal stimulus in support of household income.”

“Absent a new round of stimulus, we fear a relapse of economic activity as labour income takes a hit, forcing some homeowners into insolvency. The percentage of US mortgages in arrears for 90 days or more has surged in recent months.”

“Risks of deleveraging notwithstanding, S&P 500 financials are outpacing the index as a whole early in Q4 (4.7% vs. 3.4%). What gives? For one thing, the yield curve is steepening – a tailwind for financials. Notwithstanding the likelihood that the pace of expansion will be much slower in coming weeks, financial markets see the growing possibility that Democrats will make a clean sweep on November 3, winning the White House and both chambers of Congress. The odds of this scenario are currently given as 62%, up markedly from less than 50% in September. Such a sweep would increase the odds of a very large stimulus package in 2021 and more upside for inflation.”  

Author

More from FXStreet Team
Share:

Editor's Picks

EUR/USD retakes 1.1800 on renewed USD weakness

EUR/USD gains ground after three days of losses, re-attempting 1.1800in the European trading hours on Thursday. The US Dollar sees fresh selling interest across the board, despite hawkish Fed Minutes, as the market mood improves and supports the pair. US Jobless Claims data, Fedspeak and geopolitics remain in focus. 

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold clings to gains above $5,000 amid safe-haven flows and Fed rate cut bets

Gold sticks to modest intraday gains, above the $5,000 psychological mark, through the first half of the European session, though it lacks bullish conviction amid mixed cues. The third round of US-mediated negotiations between Ukraine and Russia concluded in Geneva on Wednesday without any major breakthrough.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.